National Program of Cancer Registries Cancer Surveillance System - Enhanced CSS Report

National Program of Cancer Registries Cancer Surveillance System

ATT 3b Enhanced NPCR CSS Submission Specifications

National Program of Cancer Registries Cancer Surveillance System - Enhanced CSS Report

OMB: 0920-0469

Document [pdf]
Download: pdf | pdf
Attachment 3b
NPCR-CER Submission Data Items
Diagnosis Year 2011

Record ID and Demographic Section—(Name and [Number])
Record Type [10]
Patient ID Number [20] (unique)
Registry ID [40]
NAACCR Record Version [50]
Address at Dx—State [80]
County at Dx [90]1
Address at Dx—Postal Code [100]
Census Tract 2000 [130]
Census Tract 2010 [135]
Census Tr Certainty 2000 [365]
GIS Coordinate Quality [366]
Census Tr Certainty 2010 [367]
Race 1 [160]
Race 2 [161]
Race 3 [162]
Race 4 [163]
Race 5 [164]
Spanish/Hispanic Origin [190]
NHIA Derived Hisp Origin [191]2
3
IHS Link [192]
Race--NAPIIA [193]2
Sex [220]
Age at Diagnosis [230]
Date of Birth [240]
Date of Birth Flag [241]
Birthplace State [252]
Birthplace Country [254]
Census Occ Code 1970-2000 [270]19
Census Ind Code 2010 [280]19
Occupation Source [290]
Industry Source [300]
Census Occ/Ind Sys 70-00 [330]
Attachment 2a-1
August 2011
NPCR-CSS 2012 Data Submission

Required Status
2011
Y
Y
Y
Y
Y
Y1
Y
As available
Y
As available
As available
Y
Y
Y
Y
Y
Y
Y
Y2
3
Y
Y2
Y
Y
Y
Y
Y
Y
Y19
Y19
As available
As available
Y

Text--Usual Occupation [310]
19
Text--Usual Industry [320]

19

Cancer Identification Section—(Name and [Number])
Sequence Number—Central [380]
Date of Diagnosis [390]
Date of Diagnosis Flag [391]
Date of 1st Contact [580]
Date of 1st Contact Flag [581]
Primary Site [400]
Laterality [410]
Grade [440]
Grade Path Value [441]
Grade Path System [449]
Diagnostic Confirmation [490]
Type of Reporting Source [500]
Histologic Type ICD-O-3 [522]
Behavior Code ICD-O-3 [523]
Site Coding Sys--Current [450]
Morph Coding Sys--Current [470]
Primary Payer at DX [630]
Treatment First Course Section—(Name and [Number])
Date Initial RX SEER [1260]

4

19

Y
19
Y
Required Status
2011
Y
Y
Y
Y
Y
Y
Y
Y
As available
As available
Y
Y
Y
Y
Y
Y
As available
Required Status
2011
Y4

Date Initial RX SEER Flag [1261]4

Y4

Date 1st Crs RX COC [1270]4

Y

Date 1st Crs RX COC Flag [1271]4
RX Date Surgery [1200]
RX Date Surgery Flag [1201]
RX Summ--Surg Primary Site [1290]
RX Summ--Scope Reg LN Sur [1292]
RX Summ--Surg Oth Reg/Dis [1294]
Reason for No Surgery [1340]
RX Date Radiation [1210]
RX Date Radiation Flag [1211]
RX Summ--Radiation [1360]
RX Summ--Surg/Rad Seq [1380]
Reason for No Radiation [1430]
RX Date Chemo [1220]
RX Date Chemo Flag [1221]
RX Summ--Chemo [1390]
RX Date Hormone [1230]
RX Date Hormone Flag [1231]
RX Summ--Horm [1400]

Y4
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y

Attachment 2a-2
August 2011
NPCR-CSS 2012 Data Submission

4

RX Date BRM [1240]
RX Date BRM Flag [1241]
RX Summ--BRM [1410]
RX Date Other [1250]
RX Date Other Flag [1251]
Rx Summ--Other [1420]
Rad--Regional Rx Modality [1570]
RX Summ--Systemic/Sur Seq [1639]
Rx Summ--Transplant/Endocr [3250]
RX Summ--Treatment Status [1285]
RX Coding System Current [1460]
First Course Calc Method [1500]
Chemo 1 NSC Number [9751]15

Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
15
Y

Chemo 2 NSC Number [9752]15

Y

Chemo 3 NSC Number [9753]15

Y15

Chemo 4 NSC Number [9754]15

Y

Chemo 5 NSC Number [9755]15

Y15

Chemo 6 NSC Number [9756]

15

15

15

15

Y

Chemo 1 Num Doses Planned [9761]15

Y15

Chemo 2 Num Doses Planned [9762]15

Y15

Chemo3 Num Doses Planned [9763]15

Y

Chemo 4 Num Doses Planned [9764]15

Y15

Chemo 5 Num Doses Planned [9765]15

Y

Chemo 6 Num Doses Planned [9766]15

Y15

Chemo 1 Planned Dose [9771]15

Y15

Chemo 2 Planned Dose [9772]15

Y15

Chemo 3 Planned Dose [9773]15

Y15

Chemo 4 Planned Dose [9774]15

Y

Chemo 5 Planned Dose [9775]15

Y15

Chemo 6 Planned Dose [9776]15

Y15

Chemo 1 Planned Dose Unit [9781]15

Y15

Chemo 2 Planned Dose Unit [9782]15

Y15

Chemo 3 Planned Dose Unit [9783]15

Y15

Chemo 4 Planned Dose Unit [9784]15

Y15

Chemo 5 Planned Dose Unit [9785]15

Y15

Chemo 6 Planned Dose Unit [9786]15

Y15

Chemo 1 Num Doses Receivd [9791]15

Y15

Chemo 2 Num Doses Receivd [9792]15

Y15

Chemo 3 Num Doses Receivd [9793]15

Y15

Attachment 2a-3
August 2011
NPCR-CSS 2012 Data Submission

15

15

15

Chemo 4 Num Doses Receivd [9794]

15

Y

Chemo 5 Num Doses Receivd [9795]

15

Y15

Chemo 6 Num Doses Receivd [9796]

15

Y

15

15

Chemo 1 Received Dose [9801]15

Y

Chemo 2 Received Dose [9802]

15

Y

Chemo 3 Received Dose [9803]

15

Y

Chemo 4 Received Dose [9804]

15

Y15

Chemo 5 Received Dose [9805]

15

Y

Chemo 6 Received Dose [9806]15

Y

15
15
15

15
15

Chemo 1 Received DoseUnit [9811]

15

Y

Chemo 2 Received DoseUnit [9812]

15

Y

Chemo 3 Received DoseUnit [9813]

15

Y15

Chemo 4 Received DoseUnit [9814]15

Y15

Chemo 5 Received DoseUnit [9815]15

Y

Chemo 6 Received DoseUnit [9816]15

Y15

15
15

15

15

Y15

Chemo 2 Start Date [9822]15

Y15

Chemo 3 Start Date [9823]15

Y15

Chemo 4 Start Date [9824]15

Y

Chemo 5 Start Date [9825]15

Y15

Chemo 6 Start Date [9826]15

Y15

Chemo 1 Start Date Flag [9831]15

Y15

Chemo 1 Start Date [9821]

Chemo 2 Start Date Flag [9832]

15

15

15

Y

Chemo 3 Start Date Flag [9833]15

Y15

Chemo 4 Start Date Flag [9834]15

Y15

Chemo 5 Start Date Flag [9835]15

Y

Chemo 6 Start Date Flag [9836]15

Y15

Chemo 1 End Date [9841]15

Y15

Chemo 2 End Date [9842]15

Y15

Chemo 3 End Date [9843]15

Y15

Chemo 4 End Date [9844]15

Y15

Chemo 5 End Date [9845]15

Y15

Chemo 6 End Date [9846]15

Y15

Chemo 1 End Date Flag [9851]15

Y15

Chemo 2 End Date Flag [9852]15

Y15

Chemo 3 End Date Flag [9853]15

Y15

Chemo 4 End Date Flag [9854]15

Y15

Attachment 2a-4
August 2011
NPCR-CSS 2012 Data Submission

15

Chemo 5 End Date Flag [9855]

15

Y

Chemo 6 End Date Flag [9856]

15

Y15

Chemo Completion Status [9859]

15

15

15

Y

Hormone 1 NSC Number [9861]15

Y

15

Y

Hormone 2 NSC Number [9862]

15
15

BRM 1 NSC [9871]

15

Y

BRM 2 NSC [9872]

15

Y15

15

Granulocyte CSF Status [9880]

15

15

Y

Erythro Growth Factor Sta [9881]15
Thrombocyte GrowthFactSta [9882]

15

Y
15

Stage/Prognostic Factors Section—(Name and [Number])
Regional Nodes Pos [820]
Regional Nodes Examined [830]
CS Tumor Size [2800]
CS Extension [2810]
CS Tumor Size/Ext Eval [2820]
CS Lymph Nodes [2830]
CS Lymph Nodes Eval [2840]
CS Mets at DX [2850]
CS Mets Eval [2860]
CS Site-Specific Factor 1 [2880]5,6

15

Y
Required Status
2011
As available
As available
Y
Y
Y
Y
Y
Y
Y
Y5,6
Y6,7

CS Site-Specific Factor 2 [2890]

6,7

CS Site-Specific Factor 3 [2900]

6

Y6

CS Site-Specific Factor 4 [2910]6

Y6

CS Site-Specific Factor 5 [2920]6,8

Y

CS Site-Specific Factor 6 [2930]6

Y6

6,9

6,8

6,9

CS Site-Specific Factor 7 [2861]
CS Site-Specific Factor 8 [2862]7

Y

CS Site-Specific Factor 9 [2863]10

Y10

CS Site-Specific Factor 10 [2864]6,11

Y6,11

CS Site-Specific Factor 11 [2865]6,12

Y6,12

CS Site-Specific Factor 12 [2866]6,7

Y6,7

CS Site-Specific Factor 13 [2867]6,7
CS Site-Specific Factor 14 [2868]7

Y6,7

CS Site-Specific Factor 15 [2869]6,7

Y6,7

CS Site-Specific Factor 16 [2870]6,7

Y6,7

CS Site-Specific Factor 17 [2871]6

Y6

CS Site-Specific Factor 21 [2875]7

Y7

Attachment 2a-5
August 2011
NPCR-CSS 2012 Data Submission

Y7

Y7

7

7

Y

CS Site-Specific Factor 23 [2877]7

Y

6

Y

CS Site-Specific Factor 22 [2876]
CS Site-Specific Factor 25 [2879]

7
6

Lymph-Vascular Invasion [1182]6
CS Version Input Original [2935]
CS Version Derived [2936]
CS Version Input Current [2937]
Derived SS2000 [3020]
Derived SS2000--Flag [3050]
Derived AJCC-7 T [3400]
Derived AJCC-7 T Descript [3402]
Derived AJCC-7 N [3410]
Derived AJCC-7 N Descript [3412]
Derived AJCC-7 M [3420]
Derived AJCC-7 M Descript [3422]
Derived AJCC 7th Edition Stage Group [3430]
TNM Clin T [940]13

Y6
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y13

TNM Clin N [950]13
TNM Clin M [960]13

Y

TNM Clin Stage Group [970]13

Y13

TNM Clin Descriptor [980]13

Y13

TNM Edition Number [1060]13
Comorbid/Complication 1 [3110]
Comorbid/Complication 2 [3120]
Comorbid/Complication 3 [3130]
Comorbid/Complication 4 [3140]
Comorbid/Complication 5 [3150]
Comorbid/Complication 6 [3160]
Comorbid/Complication 7 [3161]
Comorbid/Complication 8 [3162]
Comorbid/Complication 9 [3163]
Comorbid/Complication 10 [3164]
Source Comorbidity [9970]21

Y13
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y21

13

Y13

Height [9960]16, 21

Y16, 21

Weight [9961]16, 21

Y16, 21

BCR-ABL Cytogenetic [9900]17

Y17

BCR-ABL Cytogenetic Date [9901]17

Y17

BCR-ABL Cytogen Date Flag [9902]17

Y17

BCR-ABL FISH [9903]17

Y17

BCR-ABL FISH Date [9904]17

Y17

BCR-ABL FISH Date Flag [9905]17

Y17

Attachment 2a-6
August 2011
NPCR-CSS 2012 Data Submission

BCR-ABL RT-PCR Qual [9906]

17

17

Y

BCR-ABL RT-PCR Qual Date [9907]

17

BCR-ABL RT-PCR Qual DtFlg [9908]

17

BCR-ABL RT-PCR Quant [9909]17
17

Y

17

Y

BCR-ABL RT-PCR Quan DtFlg [9911]
20, 21

Tobacco Use Other Smoke [9966]

17
17

20, 21

Y

20, 21

Tobacco Use Smokeless [9967]20, 21
Tobacco Use NOS [9968]

17

Y

Y17

BCR-ABL RT-PCR Quant Date [9910]
Tobacco Use Cigarettes [9965]

17

Y

20, 21

Y

Y20, 21

20, 21

20, 21

Subsequent Treatment—(Name and [Number])
Reason Subsq RX [9920]18

Y
Required Status
2011
As available18

Subsq RX 2nd Course Date [1660]18
Subsq RX 2nd DateFlag CER [9955]18
Subsq RX 2ndCrs Surg [9921]18
Subsq RX 2ndCrs Rad [9922]18
Subsq RX 2ndCrs Chemo [9923]

18

Subsq RX 2ndCrs Horm [9924]18
Subsq RX 2ndCrs BRM [9925]18
Subsq RX 2ndCrs Oth [9926]18
Subsq RX 2ndCrs Trans/End [9927]

18

Subsq RX 2nd Chemo 1 NSC [9931]18
Subsq RX 2nd Chemo 2 NSC [9932]18
Subsq RX 2nd Chemo 3 NSC [9933]

18

Subsq RX 2nd Chemo 4 NSC [9934]18
Subsq RX 2nd Chemo 5 NSC [9935]18
Subsq RX 2nd Chemo 6 NSC [9936]18
Subsq RX 2nd Horm 1 NSC [9941]18
Subsq RX 2nd Horm 2 NSC [9942]18
Subsq RX 2nd BRM 1 NSC [9951]18
Subsq RX 2nd BRM 2 NSC [9952]18
Follow-Up/Recurrence/Death Section—(Name and [Number])
Date of Last Contact [1750]
Date of Last Contact Flag [1751]
Vital Status [1760]
Follow-Up Source Central [1791]
Cause of Death [1910]
Attachment 2a-7
August 2011
NPCR-CSS 2012 Data Submission

Required Status
2011
Y
Y
Y
Y
Y

ICD Revision Number [1920]
Place of Death--State [1942]
Place of Death--Country [1944]
Over-Rides/Conversion/System Admin. Section—(Name and [Number])
Over-Ride Age/Site/Morph [1990]
Over-Ride SeqNo/DxConf [2000]
Over-Ride Site/Lat/Sequence Number [2010]
Over-Ride Surg/Dxconf [2020]
Over-Ride Site/Type [2030]
Over-Ride Histology [2040]
Over-Ride Report Source [2050]
Over-Ride Ill-define Site [2060]
Over-Ride Leuk, Lymphoma [2070]
Over-Ride Site/Behavior [2071]
Over-Ride Site/Lat/Morph [2074]
NPCR Site-Specific Factors
EDP MDE Link Variable [9980]14

Y
Y
Y
Required Status
2011
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Required Status
2011
Y14

EDP MDE Link Date [9981]14

Y14

CER Over-Ride[9969]22

Y22

NOTES:
The data item names and numbers are those used in NAACCR Volume II, Version 12.2.
Status key: Y = Yes
1
Code “999” for unknown and invalid. Do not include cases with code “998” in the submission file.
2

Report the results from the combined NHIA/NAPIIA (NHAPIIA) SAS Program. See the Submission
Specifications document and/or Atachment 1 for more details. Please note that code 9, unknown, is not a
valid code for the NHIA data item.
3

Report the results of cases submitted for IHS linkage using codes 0 or 1. See the Submission Specifications
document for further details.

4

Submit either the SEER or COC field.

5

Required for Breast, Brain, CNS Other, Intracranial Gland, Hematopoietic, Reticulendothelial,
Immunoproliferative, Myeloproliferative, Myelodysplastic Disease.
6

Required as needed to derive AJCC 7th TNM Stage and Summary Stage 2000 for all sites/histologies.
Required for Breast.
8
Required for Rectum.
9
Required for Colon, Rectum, Appendix.
10
Required for Breast, Colon, Rectum.
11
Required for Breast, Colon, Rectum, Appendix.
12
Required for Breast, Appendix, GIST Appendix, GIST Colon, GIST Rectum.
7

Attachment 2a-8
August 2011
NPCR-CSS 2012 Data Submission

13

Required for reportable breast and rectum cases diagnosed 2011.
For linkage results of reportable breast, cervical, and colorectal cancer cases. Report the EDP MDE Link
Variable in column 1306 and the EDP MDE Link Date in columns 1307-1314 as instructed in the November
2013 NPCR-CER Submission Specifications.

14

15

Required for Breast, Colorectal, CML.

16

Required for Breast, Colorectal, CML if chemotherapy and/or other drugs received. As available for all
other sites/histologies.
17

Required for CML.

18

As available for Breast, Colorectal, CML.

19

For Occupation and Industry variables, either the coded fields OR the text fields are required for CER
submission from all states.

20

As clarified in July 2011 in the data dictionary: For all sites/histologies, "blanks" are not permitted and code
"9" should be used to reflect unknown tobacco use. The CDC will use the volume of cases coded to "9" to
help determine the availability of information related to tobacco use in the medical record.
21
Report the permanently-assigned data items for 2011 forward in the designated columns. Height 1315-1316,
Weight 1317-1319, Tobacco Use Cigarettes 1320-1320, Tobacco Use Other Smoke 1321-1321, Tobacco Use
Smokeless 1322-1322, Tobacco Use NOS 1323-1323, Source Comorbidity 1324-1324.

22

Set CER Over-Ride [column 1325] to "1" only when the 2011 diagnosis year case was received after the
close of the CER data collection period. Otherwise, this column is to be blank.

Attachment 2a-9
August 2011
NPCR-CSS 2012 Data Submission

Attachment 2a-10
August 2011
NPCR-CSS 2012 Data Submission

Attachment 2a-11
August 2011
NPCR-CSS 2012 Data Submission

remove for 2015

Attachment 2a-12
August 2011
NPCR-CSS 2012 Data Submission


File Typeapplication/pdf
File TitleATT 3b Enhanced NPCR CSS Submission Specifications.xls
AuthorZTQ6
File Modified2016-03-17
File Created2016-03-17

© 2024 OMB.report | Privacy Policy